Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice.
暂无分享,去创建一个
[1] Shuxian Hu,et al. Cytokine regulation of human microglial cell IL-8 production. , 1998, Journal of immunology.
[2] J. Licinio,et al. Pathways and mechanisms for cytokine signaling of the central nervous system. , 1997, The Journal of clinical investigation.
[3] E. Chi,et al. Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. , 1997, The Journal of clinical investigation.
[4] P. Picton,et al. Aseptic meningitis associated with high dose immunoglobulin: case report , 1997, BMJ.
[5] W. Karpus,et al. MIP‐1α and MCP‐1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphoctye differentiation , 1997, Journal of leukocyte biology.
[6] M. Chamberlain,et al. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. , 1997, Journal of neurosurgery.
[7] J. Bluestone,et al. Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. , 1997, Journal of immunology.
[8] V. Kuchroo,et al. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. , 1997, Journal of immunology.
[9] Steven Jarrett,et al. Ibuprofen-Induced Aseptic Meningitis in Rheumatoid Arthritis , 1997, The Annals of pharmacotherapy.
[10] H. Koeffler,et al. The production of IL‐8 in cerebrospinal fluid in aseptic meningitis of children , 1997, Clinical and experimental immunology.
[11] N. Gilroy,et al. Trimethoprim-induced aseptic meningitis and uveitis , 1997, The Lancet.
[12] Stiehm Er. Human intravenous immunoglobulin in primary and secondary antibody deficiencies. , 1997 .
[13] B. Rudy,et al. Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent. , 1997, Pediatric emergency care.
[14] P. Nickerson,et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. , 1997, Journal of immunology.
[15] M. Dalakas. Intravenous Immune Globulin Therapy for Neurologic Diseases , 1997, Annals of Internal Medicine.
[16] R. Strieter,et al. C-C chemokines differentially alter interleukin-4 production from lymphocytes. , 1997, The American journal of pathology.
[17] W. Karpus,et al. Differential CC chemokine-induced enhancement of T helper cell cytokine production. , 1997, Journal of immunology.
[18] Hans Hengartner,et al. Antigen localisation regulates immune responses in a dose‐ and time‐dependent fashion: a geographical view of immune reactivity , 1997, Immunological reviews.
[19] J. Allison,et al. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis , 1997, Journal of Neuroimmunology.
[20] K. Frei,et al. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. , 1997, Journal of immunology.
[21] D. Taub. Chemokine-leukocyte interactions. The voodoo that they do so well. , 1996, Cytokine & growth factor reviews.
[22] A. Ben-nun,et al. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse Vβ gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor Vβb and T cell receptor Vβa H‐2b mice , 1996 .
[23] C. June,et al. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. , 1996, Journal of immunology.
[24] Nitin J. Karandikar,et al. CTLA-4: a negative regulator of autoimmune disease , 1996, The Journal of experimental medicine.
[25] D. Harlan,et al. Protection against lethal toxic shock by targeted disruption of the CD28 gene , 1996, The Journal of experimental medicine.
[26] L. Steinman. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] H. Gin,et al. Recurrent aseptic purulent meningitis in a patient with relapsing polychondritis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] Nitin J. Karandikar,et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. , 1995, Immunity.
[29] J. Bluestone,et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.
[30] C. June,et al. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. , 1995, The Journal of clinical investigation.
[31] R. Swanborg. Animal models of human disease : experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease , 1995 .
[32] J. Pachón,et al. Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: its possible role as neutrophil chemotactic factor. , 1995, The Journal of infectious diseases.
[33] C. Thompson,et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.
[34] A. Ben-nun,et al. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells , 1995, European journal of immunology.
[35] R. Karr,et al. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. , 1995, The Journal of clinical investigation.
[36] D. Loh,et al. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. , 1995, Journal of immunology.
[37] Laurie H Glimcher,et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.
[38] P. Albert,et al. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. , 1995, Journal of immunology.
[39] J. Bluestone,et al. The B7 and CD28 receptor families. , 1994, Immunology today.
[40] J. Gribben,et al. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production , 1993, The Journal of experimental medicine.
[41] J. Gribben,et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. , 1993, Science.
[42] G. Freeman,et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. , 1993, Science.
[43] T. Abe,et al. Stroke and meningitis in a case of SLE with anti‐phospholipid antibodies , 1993, Acta paediatrica Japonica : Overseas edition.
[44] G. Hansson,et al. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls , 1993, Annals of neurology.
[45] K P Lee,et al. Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.
[46] C. Vedeler,et al. [Mollaret's meningitis]. , 1990, Tidsskrift for Den Norske Laegeforening.
[47] T. Wullen,et al. [Mollaret benign recurrent aseptic meningitis. Case report, results of cerebrospinal fluid cytology and review of the literature]. , 1990, Der Nervenarzt.
[48] R. Schwartz,et al. A cell culture model for T lymphocyte clonal anergy. , 1990, Science.
[49] L. Saravolatz,et al. Aseptic meningitis complicating adult Kawasaki disease: case report and review of the literature. , 1989, The American journal of medicine.
[50] C. Thompson,et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Corry,et al. Nosocomial aseptic meningitis associated with administration of OKT3. , 1988, JAMA.
[52] K. A. Wall,et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.
[53] C. Pettinelli,et al. Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. , 1982, Journal of immunology.
[54] S. Kunkel. Th1- and Th2-type cytokines regulate chemokine expression. , 1996, Biological signals.
[55] P. Laterre,et al. [Neurological Disorders Revealing Behcet Disease - 4 Clinical Case-reports] , 1990 .
[56] P. Laterre,et al. [Neurological involvement as manifestation of Behçet's disease. 4 clinical case reports]. , 1990, Acta Neurologica Belgica.
[57] C. Beil,et al. Quantitation of lymphocyte subsets in cerebrospinal fluid and blood during the clinical course of aseptic and bacterial meningitis. , 1990, European Neurology.
[58] P. Linsley,et al. Role of the CD28 receptor in T-cell activation. , 1990, Immunology today.